Eledon Pharmaceuticals Inc. (NASDAQ: ELDN) trades around the $3.46 per share price level. As a clinical-stage biopharmaceutical equity, its market valuation fluctuates dynamically in response to clinical trial data updates, regulatory announcements, biotech sector trends, and capital-raising activities. Investors track real-time quotes, trading volumes, and daily price bands across major market data portals and brokerage platforms.